Radiation Risk in Patients Undergoing SPECT MPI
pathways has not been fully explored. In this study, we examined the effects of low-dose radiation on the DNA damage response pathways in T lymphocytes isolated from adult patients undergoing SPECT MPI using quantitative flow cytometry and singlecell gene expression profiling.
Methods

Patient Population and Clinical Imaging Studies
For this study, we recruited a total of 90 adult patients aged ≥18 years, who underwent a clinically indicated SPECT imaging examination (n=63), invasive coronary angiogram (n=12; as a positive control), or echocardiography (n=15; as a negative control) at the Veterans Affairs Palo Alto Health Care System (Figure 1 ). For SPECT MPI, patients underwent a Technetium-99m (Tc-99m) tetrofosmin rest/exercise same day protocol (Figure 2A ). The mean injected dose during rest was 6.9±0.5 millicuries (mCi). For the stress study, the dose averaged 23.8±1.4 mCi. The injection of a second dose of radionuclide occurred within ≈1.5 hours of the first dose. All examinations were performed using an Infinia Hawkeye 3.0 (GE, Milwaukee, WI).
Coronary catheterization was performed in standard views using the Innova Interventional x-ray system (GE). All transthoracic echocardiograms were performed using a VIVID7 ultrasound machine (GE). Demographic and clinical information was obtained from the electronic medical record. Informed consent was obtained from all patients.
Sample Collection
For the in vitro study, peripheral blood from healthy volunteers was drawn into vacutainer tubes containing EDTA and placed immediately on ice before irradiation. Sixteen cc of whole blood from healthy volunteers (4 cc per each irradiation dose; n=13) was collected for evaluation of proteomic changes ( Figure 2B ). To determine gene expression, 12 cc of blood (3 cc at each timepoint) was collected from individual donors (n=3).
For the in vivo study, blood samples were collected from each patient before and after the medical imaging procedure ( Figure 2C ). DNA repair was then arrested by placing the samples immediately on ice. Specifically, for SPECT MPI, we obtained blood samples at 2 hours after the first injection dose (ie, ≈30 minutes after the second injection dose), and the percent of cells expressing phosphorylated DNA damage markers was measured by quantitative flow cytometry. In a subset of patients, SPECT additional samples were taken after the second injection dose to examine the kinetics of γH2AX formation, and loss overtime by quantitative flow cytometry (eg, at 15 and 30 minutes) and immunocytochemistry (eg, at 5, 15, 30, 60, and 120 minutes). To determine the changes in gene expression after SPECT MPI, blood samples were obtained at baseline and then at 2, 6, 24, and 48 hours after the second injection dose. Expression of selected DNA damage response genes was assessed by quantitative single-cell real-time polymerase chain reaction (PCR). In addition, blood samples were collected from patients at similar timepoints before and after invasive x-ray angiography or echocardiography for protein phosphorylation and gene expression analysis, respectively.
Estimation of Radiation Dose
Effective dose equivalent from SPECT was calculated from the injected radiotracer dose according to the International Commission on Radiological Protection Publication 106, using the following conversion factors: (1) Rest=0.0080 mSv/MBq and (2) Stress=0.0069 mSv/ MBq. 12 Effective dose equivalent from invasive x-ray angiography was calculated according to a previous report (0.22 mSv/Gy cm 2 ). 13 Total dose-area product, measured in cGy cm 2 , is included in Table I in the Data Supplement.
Quantitative Flow Cytometry
T lymphocytes were isolated from whole blood using the RosetteSep Human T Cell Enrichment Cocktail (Stem Cell Technologies, Inc, Vancouver, Canada), according to the manufacturer's protocol.
Briefly, blood samples were incubated with RosetteSep Human T Cell Enrichment Cocktail for 20 minutes at room temperature. After density gradient centrifugation on Ficoll-Paque Plus (Amersham/GE Healthcare, Piscataway, NJ), the enriched T lymphocytes expressing CD3 + were collected from the interface between the density medium and plasma. After fixation, cell permeabilization was carried out on ice for 10 minutes. Total and phosphorylated forms of H2AX were determined by labeling cells with either anti-histone H2AX-FITC or anti-phospho-histone H2AX-PerCP (FlowCellect Dual Detection kits; Millipore, Billerica, MA) for 30 minutes in the dark at room temperature. To measure the phosphorylated form of ataxia telangiectasia mutated (ATM) and tumor protein 53 (p53), cells were labeled with anti-phospho ATM-PE (Millipore) or anti-phospho-p53-FITC (Cell Signaling Technologies, Inc, Danvers, MA) in the dark on ice for 60 minutes, respectively. Finally, cells were resuspended in fluorescenceactivated cell sorting buffer (Dulbecco's phosphate-buffered saline with 2% fetal bovine serum and 2 mmol/L EDTA) and analyzed using an LSRII flow cytometer (BD Biosciences, San Jose, CA). Fluorochrome and isotype-matched controls (PerCP-IgG1, FITC-IgG, and PE-IgG1κ; Millipore), as well as unlabeled samples were used to set the appropriate gate parameters and served as negative controls (data not shown). A total of 10 000 events were recorded in each analysis. Data analysis was conducted using the FlowJo software (Tree Star, Ashland, OR).
Single-Cell Quantitative Real-Time PCR
Peripheral blood mononuclear cells were isolated from the buffy coat after density gradient centrifugation on 1.077 g/mL Ficoll-Paque Plus.
B C In Vitro Studies
In Vivo Studies Freshly isolated peripheral blood mononuclear cells were preincubated with 20 μL of Fc receptors-blocking reagent (Miltenyi, Auburn, CA) and stained with 5 μL of Alexa Fluor 647 mouse antihuman CD3 antibody (BD Biosciences) by incubating cells in 100 μL of fluorescenceactivated cell sorting buffer on ice for 20 minutes. The specificity of staining was confirmed by using an isotype-matched control antibody (Alexa Fluor 647-IgG1κ; BD Biosciences). Dead cells were excluded by adding 7-amino-actinomycin D to the cell suspension before sorting. Using a fluorescence-activated cell sorting Aria (BD Biosciences), cells (CD3 + and 7-amino-actinomycin D − ) were sorted directly into 96well 0.2-mL PCR plates, containing buffers and enzymes for reverse transcription according to the manufacturer's instructions (Fluidigm, South San Francisco, CA), as described previously. 14 ) , which measures target transcript abundance in the samples and is analyzed using an equation that was described previously. 15 All reactions were performed in duplicates or triplicates.
Protocol for SPECT Myocardial Perfusion Imaging A
Immunocytochemistry
Isolated T lymphocytes (≈1.6×10 5 cells/150 μL per slide) were spun onto Superfrost/Plus microscope slides (Fisher Scientific, Pittsburgh, PA) using the Cytospin 4 (Thermo Scientific, Waltham, MA) at 500 rpm for 5 minutes at low acceleration. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature. After rinsing with PBS, cells were blocked, and permeabilized in 5% bovine serum albumin and 0.2% Triton X-100 for 1 hour at room temperature, followed by incubation with primary antibodies, including mouse anti-γH2AX monoclonal antibody (Millipore) and rat anti-CD3 monoclonal antibody (AbDSerotec, Düsseldorf, Germany) diluted in antibody diluent buffer (IHC World, Woodstock, MD) overnight at 4°C. Cells were then washed with 0.2% Tween-20 in PBS. After additional rinsing with PBS, cells were incubated in the dark for 1 hour with a secondary antibody, either goat-anti-mouse IgG-conjugated with Alexa Fluor 488 or goat-anti-rat IgG-conjugated with Alexa Fluor 594. The slides were washed and nuclei were counterstained with 4′,6-diamidino-2-phenylindole. The number of γH2AX (phosphorylated at serine 139) foci per lymphocyte was determined using a fluorescence microscope with ×40 magnification. Forty cells were counted by 2 blinded observers.
Statistical Analysis
All statistical analysis of data was completed using SigmaStat 3.5 (SPSS Inc, Chicago, IL). Changes in protein phosphorylation and gene expression before and after medical imaging (ie, SPECT MPI, invasive x-ray angiography, and echocardiography) were compared with a paired t test and Wilcoxon signed-rank test with Bonferroni correction for normally and non-normally distributed data, respectively. To test for serial changes in protein activation and gene expression, a one-way repeated-measures ANOVA with Bonferroni post hoc analysis was used. If data were not normally distributed, the Friedman repeated-measures ANOVA, followed by Wilcoxon signedrank test with Bonferroni correction, was conducted. For analysis of individual variation in activation of DNA damage response proteins, patients were divided into 2 groups, such as (1) those with marked increased phosphorylation (+) and (2) those with no marked change (−). A marked increase in phosphorylation was defined as an increase in phosphorylation of ≥1% (≥100 events) compared with baseline. By contrast, the negative control group showed a minor increase of <1% positive cells before and after echocardiography. For analysis of individual variation in gene expression, patients were grouped into the following categories, such as (1) those with marked upregulation (up), (2) those with marked downregulation (down), and (3) those with no marked change (no change). Marked upregulation and downregulation were defined as ≥1.5-fold increase and ≥1.5-fold decrease (ie, ≤0.67 change) in gene expression, respectively.
All values were expressed as mean±SEM and statistical probability of adjusted P<0.05 (Bonferroni correction) was considered significant. Bonferroni correction was used for multiple comparisons, with P<0.05 (adjusted for the number of comparisons) being considered significant.
Results
Demographics and Clinical Characteristics
A total of 63 patients were recruited for the evaluation of protein phosphorylation (n=45) or gene expression (n=49) after SPECT MPI (Figure 1 ). Thirty-one patients underwent evaluation for both the changes in protein phosphorylation and gene expression, whereas 14 and 18 patients were evaluated for either protein phosphorylation or gene expression, respectively. Serial blood samples were collected in a subset of 7 patients to evaluate the kinetics of γH2AX formation and loss using immunohistochemistry. The time course of gene expression was also analyzed by collecting serial blood samples from a subset of 27 patients (baseline, 2, 6, 24, and 48 hours post-SPECT). The majority of patients undergoing SPECT MPI were white (73.0%), men (95.2%), and overweight (average body mass index, 30.7±9.6 kg/m 2 ) with significant previous or active smoking history (74.6%), but no history of previous malignancy (66.7%). The average age was 69.6±10.5 years. Most patients underwent exercise testing (55.6%), with the remainder undergoing pharmacologic stress testing. Average rest, stress, and total effective doses were 2.7±0.6, 8.1±0.4, and 10.7±0.4 mSv, respectively. In addition, as a positive control, a total of 12 patients were recruited for the evaluation of protein phosphorylation (n=12) and gene expression (n=10) after invasive x-ray angiography. Samples were also collected from a total of 15 patients undergoing echocardiography (as a negative control) for analysis of protein phosphorylation (n=9) and gene expression (n=11), respectively. The demographics and clinical characteristics for the invasive x-ray angiography and echocardiography patients are included in the Table I in the Data Supplement and were not significantly different from the patients undergoing SPECT MPI.
Phosphorylation of DNA Damage-Marker Proteins After SPECT MPI
To examine the effects of radiation exposure from SPECT MPI, we measured the phosphorylation of 3 DNA damage-marker proteins (H2AX, p53, and ATM) which are often used as indicators of radiation-induced cellular damage. 4, [16] [17] [18] We collected T lymphocytes from patients before and after SPECT. Overall, analysis of all recruited patients (n=45; closed circle) showed no marked differences in phosphorylation for all 3 proteins after SPECT when compared with baseline value ( Figure 3A ). Analysis of individual responses, however, showed that some patients (ie, 35.6%; n=16/45; open circle) had increased protein phosphorylation post-SPECT ( Figure 3A ). Consistent with these findings, blood samples drawn from healthy volunteers (n=4-8) subjected to a single dose of in vitro radiation (of varying intensity) showed no marked changes in phosphorylation of measured proteins at lower doses (12.5 and 25 mGy; closed squares). This is equivalent to the amount of radiation exposure from SPECT MPI, which is ≈10 mGy ( Figure I To evaluate the sensitivity of quantitative flow cytometry for detecting small changes in phosphorylation in vivo and to verify that peak changes in phosphorylation occurred at 30 minutes in most patients, we next measured serial changes in protein phosphorylation using immunohistochemistry (n=7), a method that has been shown to detect these changes after exposure to radiation doses as low as 1.2 mGy in vitro. 19 Consistent with other studies, 4,20 γ-H2AX foci seemed as early as 5 minutes postradiation, reached a maximum at 15 to 30 minutes, and decreased thereafter ( Figure 3B and 3C). No significant differences were found in the change in phosphorylation of H2AX by immunohistochemistry ( Figure 3C ) and quantitative flow cytometry ( Figure 3D ) compared with baseline, defined as an excess of 1 foci per cell and an 1% increase in events, respectively, although considerable variation was seen among patients using both assays (Table III in  the Data Supplement) . Importantly, the 2 observers showed moderately high agreement for counting the average foci per cell for each immunohistochemistry sample (Intraclass correlation coefficient, 0.763).
Interestingly, T lymphocytes isolated from patients after invasive x-ray angiography, an imaging modality that exposes patients to short bursts of radiation that were on average higher than SPECT MPI (average dose, 18.2±10.6 mSv; Table I in the Data Supplement), showed significantly higher phosphorylation of H2AX (3.61±0.50% versus 2.14±0.04%; P=0.004), p53 (6.68±1.42% versus 3.75±0.10%; P=0.015), and ATM (7.44±1.99% versus 2.05±0.05%; P=0.004) compared with baseline ( Figure IIA 
Changes in mRNA Expression of DNA Damage Response Genes After SPECT MPI
Because exposure to radiation is known to modulate gene expression, we selected 21 candidate genes based on previous microarray studies performed on human lymphocytes in response to a range of low-dose irradiation (0-100 mGy). [21] [22] [23] [24] In vitro single-cell quantitative real-time PCR assays were performed to investigate the temporal expression of these genes in human T lymphocytes after exposure to fractionated doses simulating SPECT imaging (eg, 25 mGy). We found an insignificant trend toward downregulation of 9 DNA damage response genes compared with sham-irradiated control ( Figure  III in the Data Supplement), with peak changes mainly occurring 24 hours postexposure before returning to basal levels at 48 hours. Importantly, there was no difference in cell viability after low radiation exposure, suggesting that T lymphocytes had a lower expression of these genes rather than a lower number of cells expressing these genes (data not shown).
Subsequently, blood samples were collected from patients before (baseline; n=49), 2 hours (2.1±0.3 hours; n=27), 6 hours (6.5±1.4 hours; n=17), 24 hours (21.8±6.7 hours; n=28), and 48 hours (47.0±0.4 hours; n=40) post-SPECT, and expression of selected genes based on our in vitro experiments were determined. Serial blood samples were initially collected to determine the optimal timing for gene expression analysis. Changes in gene expression were detectable as early as 2 hours postradiation and in some patients were extended to 48 hours ( Figure IV in the Data Supplement). In addition, most patients showed a consistent pattern of upregulation, downregulation, or no regulation of each gene, with most changes still detectable ≤24 or 48 hours ( Table IV in Analysis of the entire cohort (n=49) revealed that mRNA expression varied significantly among individuals (Figure 4 ), similar to changes in phosphorylation. On average, singlecell gene expression analysis of T lymphocytes at 24 hours post-SPECT demonstrated a trend toward downregulation of selected genes (Bax, 0.85-fold; Ddb2, 0.84-fold; Mdm2, 0.83-fold; and Tp53, 0.86-fold), although this was not statistically significant except for Atf6 (0.74-fold; P=0.002) and Bbc3 (0.66-fold; P=0.012). Changes in gene expression were still detectable at 48 hours in some patients, but seemed to return to basal expression in the majority of patients, in line with our in vitro findings. To further assess overall patterns of gene changes overtime in patients after SPECT, patients were split into 3 groups according to the relative mRNA expression in each gene, classified as down (≥1.5-fold decrease), up (≥1.5-fold increase), or no change ( Figure V 
Correlation Between Protein Phosphorylation and mRNA Expression of DNA Damage Response Genes
Considering that a small fraction of patients showed increased protein phosphorylation and elevated gene expression of DNA damage response genes in response to SPECT MPI, we determined the correlation between protein activation and mRNA expression of DNA damage response genes. We first separated patients (n=45; Figure 3A ) into 2 groups based on their phosphorylation positivity (+ represents phosphorylation ≥1%, whereas − represents phosphorylation <1%). Sixteen of 45 patients (group +) had marked increases in protein phosphorylation (γ-H2AX: 4.40±0.93% versus 2.30±0.04%, P=0.006; phospho-p53: 7.90±1.72% versus 4.00±0.07%, P=0.002; phospho-ATM: 4.47±1.24% versus 2.13±0.04%, P=0.012; n=16, Figure 5A ), whereas the remaining patients (group -) had little or no change (n=29; Figure 5A ). These results suggest that some patients may be more susceptible to cellular damage after low-dose radiation exposure. Of these 16 positive patients, only 3 showed an increase in all 3 proteins compared with baseline ( Figure 5B ). Both subgroups of patients did not differ with respect to demographic or clinical characteristics (Table) .
Interestingly, patients with increased phosphorylation had significant upregulation of genes associated with DNA damage (Bax: 1.71-fold, P=0.048; Mdm2: 1.65-fold, P=0.048; Ddb2: 1.89-fold, P=0.018; and Tp53: 1.87-fold, P=0.048; Figure 5C ) at 48 hours post-SPECT, whereas those with no changes in phosphorylation had either significant downregulation (Mdm2: 0.73-fold, P=0.003; Ddb2: 0.60-fold, P=0.007) or no difference (Bax, Tp53, Atf6, and Bbc3) compared with Radiation Risk in Patients Undergoing SPECT MPI baseline ( Figure 5D ). Taken together, these findings suggest that increased gene transcription occurs in tandem with increased phosphorylation of DNA damage-marker proteins in a subset of patients undergoing SPECT MPI.
Evaluating Potential Factors Affecting Activation of the DNA Damage Response Pathways
To define factors that might contribute to the variability of protein activation and gene expression better, blood obtained from healthy volunteers with different age groups was exposed to 25 mGy of low-dose radiation in vitro. Although not statistically significant, T lymphocytes isolated in the young age group (20-25 years) seemed to have higher levels of phosphorylation compared with the middle age group (40-55 years), whose results were more comparable with those from our cohort of older individuals (mean age, 69.6±10.5 years; Figure VIA and VIB in the Data Supplement). These findings were supported by a trend toward upregulation in DNA damage response genes in the young age group compared with a lack of gene activation in the middle age group, which was consistent with our previous studies ( Figure VIC and VID in the Data Supplement). Previous studies also have reported that certain subpopulations of T lymphocytes may be more sensitive than others to radiation. 25 To address whether this contributed to variability in the gene expression data, we next measured the effects of low-dose radiation (eg, 25 mGy) on the gene expression of central memory and naive CD4 + and CD8 + T lymphocytes. As shown in Figure VII single-cell PCR analyzed the expression of only a small set of cells, these differences in gene expression of T-lymphocyte subpopulations may have contributed to the interindividual variability seen in our gene expression data. 26
Discussion
SPECT MPI is a widely used noninvasive imaging technique for the diagnosis, risk stratification, and management of patients with coronary artery disease. Perfusion abnormalities are one of the earliest manifestations of ischemia, preceding the development of wall motion abnormalities and changes in the ECG detected by stress echocardiography and exercise treadmill testing, respectively. 27 Patients with normal or low-risk findings on SPECT have a <1% risk of developing a major adverse cardiac event at follow-up, which equates to a 98% negative predictive value for SPECT MPI. However, patients with high-risk features, such as extensive myocardial ischemia and myocardial perfusion defects involving multiple vascular territories have a predictive annual mortality of 3%. Not surprisingly, the diagnostic and prognostic accuracy of SPECT has led to a rapid increase of its use. Geographical variations in the use of SPECT MPI, however, have raised questions of overuse and concerns about unnecessary radiation exposure and its potential deleterious effects. 28 In this prospective cohort study, we found that patients undergoing SPECT MPI had variable activation of the DNA damage response pathways. Most patients did not have significant changes in phosphorylation of DNA damage-marker proteins (ie, H2AX, p53, and ATM), nor were there significant changes in mRNA expression of DNA damage response genes (ie, Bax, Mdm2, Ddb2, and Tp53) detected in T lymphocytes collected from patients post-SPECT compared with baseline. We did, however, notice a small cohort of patients who had increased protein phosphorylation post-SPECT, which was associated with upregulation of genes involved in the DNA damage response pathways.
Exposure to high-dose radiation results in cellular injury that activates the DNA damage response pathways, which has emerged as a surrogate marker of DNA damage. Previous studies have found a strong correlation between the number of double-stranded breaks and the degree of phosphorylation of proteins involved in the DNA damage response pathways. 16, 17, 29 Recent studies have also shown that exposure of human blood cells to high doses of radiation (>100 mGy) significantly increases expression of genes involved in these pathways in a dose-dependent manner. 21, 30 Similarly, other studies have found increased activation of these pathways in patients treated with high-dose radiation therapy (>100 mGy). 31, 32 Importantly, activation of the DNA damage response pathways has also been reported for lowdose radiation (<100 mGy) exposure in vitro and in vivo. Separate studies have reported increased phosphorylation of H2AX in T lymphocytes isolated from all adult patients after computed tomography imaging in a dose-dependent manner, but its effect on other DNA damage proteins remains largely unknown. 4,19,20 Our results indicate a variable activation of DNA damage response pathways in patients undergoing SPECT MPI. Two thirds of patients (n=29/45) had no change in protein phosphorylation, whereas a third of patients had evidence of increased phosphorylation in ≥1 protein marker of DNA damage. These findings are in stark contrast to results from another imaging modality, invasive x-ray angiography, in which all patients (n=12/12) undergoing cardiac catheterization had increased levels of protein phosphorylation in at least one of the protein markers of DNA damage that we tested.
In addition to reports showing increased protein phosphorylation after low-dose radiation exposure, changes in gene expression have been reported in vitro. 24 Using a DNA microarray, Nosel et al 24 found both upregulation and downregulation of genes involved in the DNA damage response pathways after exposure to 25 to 500 mGy of radiation in vitro. Interestingly, at 25 mGy, only genes involved in the regulation of cell death processes but not genes in cell cycle regulation were induced; this is consistent with both our in vivo and in vitro data, although differences in gene expression between baseline and post-SPECT were not significant. In fact, only 6 genes (Bax, Tp53, Ddb2, Mdm2, Atf6, and Bbc3) were found to be the most responsive in T lymphocytes after exposure to low-dose radiation. Similar to changes in protein phosphorylation, we observed more consistent upregulation of genes in patients undergoing invasive x-ray angiography. This is in contrast to those undergoing SPECT MPI, for which most patients showed downregulation or no change in mRNA expression of these genes within 48 hours postexposure, once again demonstrating that SPECT produces a variable activation of the DNA damage response pathways. It should be noted that compared with either invasive x-ray angiography or SPECT MPI, we did not observe any changes in either protein phosphorylation or gene expression in patients undergoing echocardiography. These results argue against the possibility that the variable activation of the DNA damage response pathways seen in patients undergoing SPECT is because of natural circadian transcriptional and post-transcriptional changes that may be unrelated to ionizing radiation.
Although this study does not explain the discrepancies observed in the extent of protein and gene activation among these patients undergoing SPECT MPI versus invasive x-ray angiography, one plausible explanation for the discrepancies may lie in the differences in the amount or frequency of dosing among these imaging modalities. Patients undergoing CT and invasive x-ray angiography are exposed to a continuous burst of radiation over a short period of time (<30 minutes), resulting in a single exposure of ≈5 to 10 mSv. Patients undergoing SPECT MPI, however, have a nuclear tracer delivered to them intravenously, in 2 divided doses (≈3 mSv followed by ≈8 mSv) separated by 90 minutes in between. It is possible that some patients undergoing SPECT MPI did not reach the threshold dose that results in DNA damage as a result of fractionated dosing.
The marked variation in response to low-dose radiation in patients undergoing SPECT MPI suggests that a subset of patients may be more sensitive to radiation. This could mean that while the majority of patients experience no changes in protein markers of DNA damage at these relatively low doses of radiation, a subset of patients experience significant changes. Interestingly, this more sensitive subset of patients with increased protein phosphorylation also had upregulation of DNA damage response genes, suggesting an ongoing activation of these pathways. Previous studies have demonstrated individual variability in radiation sensitivity at the level of gene expression. 33, 34 Using genetic mapping, Smirnov et al 33 identified individual polymorphisms in regulators of gene expression that contributed to individual differences in radiation sensitivity. However, questions as to whether there is any genetic predisposition among certain patients affecting the cellular response to SPECT MPI, or whether these changes at both the gene and protein levels reflect persistent DNA damage, are beyond the scope of this study.
There are several limitations to this study. First, we did not measure gene and protein changes at multiple timepoints in vivo in all patients; thus, it is possible that we might have missed the exact peak changes in response. However, our initial studies in a subset of patients showed that changes in protein phosphorylation and gene expression are still detectable at 30 minutes and 24 to 48 hours, respectively. Second, SPECT may produce changes in protein phosphorylation that are undetectable by flow cytometry. The advantage of flow cytometry is its ability to simultaneously screen thousands of cells for multiple markers of DNA damage. Although this technique is potentially less sensitive than immunohistochemistry, we found no significant differences in phosphorylation changes as measured by flow cytometry versus immunohistochemistry in a subset of patients. Third, we did not directly measure DNA damage, and it is possible that patients who have greater activation of these pathways might not have more double-stranded breaks, but were somehow able to Data presented as mean±SD or percentages. BMI indicates body mass index; CT, computed tomography; MPI, myocardial perfusion imaging; mSv, millisievert; and SPECT, single-photon emission computed tomography. Radiation Risk in Patients Undergoing SPECT MPI respond to small doses of radiation better. Thus the persistence of induced DNA damage is unknown, and there are no available techniques to directly quantify a small number of double-stranded breaks. Finally, a demonstration of variable DNA damage pathway activation induced by SPECT does not necessarily equate to increased cancer risk. Our results were determined in peripheral blood lymphocytes, which are one of the most radiosensitive cell types in the body, but nevertheless may not directly lead to cancer. 35 Rather, our results represent a snapshot of the cellular response to SPECT-induced radiation damage. In addition, the small increased risk in cancer induction because of radiation is particularly difficult to detect as it is neither differentiable nor predictable for individual patients. This is further complicated by the omnipresent background radiation and also the fact that inherent (baseline) risk of cancer is much higher than the potential risk of radiationinduced cancer. 3, 35, 36 Hence, determining specific cancer risks is beyond the scope of this study and is probably not feasible using any existing strategies.
Taken together, our results show that the majority of patients undergoing SPECT MPI did not show an activation of the DNA damage response pathways. However, a small minority of patients did experience increased phosphorylation, which is associated with upregulation of genes involved in the DNA damage response pathways. The variable activation induced by SPECT differed from that seen in invasive x-ray angiography, which produced a uniform activation pattern; it was also different compared with echocardiography, which showed an absence of activation of the DNA damage response pathways. It is reasonable to conclude that although the risk of low-dose radiation from SPECT MPI remains a valid concern, most patients who undergo imaging for diagnosis and risk stratification are often of advanced age and may benefit more from cardiac imaging procedures relative to the potential harms of radiation-based imaging during the remainder of their expected life span. 36 However, our results also show that the risk of low-dose radiation is not zero, and, therefore, it should continue to be standard practice to perform all imaging studies at the lowest possible radiation dose without compromising diagnostic image quality.
